Regulus

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

Published December 4, 2008, 6:47 am, Centre Daily Times

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has been selected as a 2009 Technology Pioneer by the World Economic Forum. Each year, the World Economic Forum awards companies from a variety of fields who have demonstrated visionary leadership and are involved in the development of a life-changing technology.

Discover News | Full Story


Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

Published December 4, 2008, 6:08 am, Business Wire via Yahoo! Finance

CAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that it has been selected as a 2009 Technology Pioneer by the World Economic Forum.

Discover News | Full Story


Isis Announces That OGX-011 Has Shown Overall Survival Advantage In Prostate Cancer Compared To Standard Therapy In A ...

Published December 4, 2008, 3:12 am, Medical News Today

Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that OncoGenex Pharmaceuticals, Inc. provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm") compared to docetaxel and prednisone alone ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer. The current 10.

Discover News | Full Story


Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a ...

Published December 3, 2008, 4:00 am, PR Newswire via Yahoo! Finance

Isis Pharmaceuticals, Inc. announced today that OncoGenex Pharmaceuticals, Inc. provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone compared to docetaxel and prednisone alone for first-line treatment of metastatic castrate resistant prostate cancer.

Discover News | Full Story


Check out tonight's sky after sunset; it may be like the one the wise men saw

Published December 2, 2008, 9:58 am, The Greenville News

If you haven't seen the southwestern sky just after sunset, and even if you have, feast your eyes tonight -- it may be the same spectacular show that drew the wise men to Bethlehem in search of a newborn king.

Discover News | Full Story


Gene Silencing Drug Shown to Block Heart Failure in Mice

Published December 1, 2008, 1:55 pm, San Diego Business Journal

A partnership forged between two former competitors has produced new scientific data that shows the potential for a new class of drugs aimed at fighting heart failure.

Discover News | Full Story


First Ever In-vivo Efficacy Data For A MicroRNA Therapeutic Disease Model

Published December 1, 2008, 12:10 pm, Medical News Today

Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure(1).

Discover News | Full Story


December: Ursid meteor shower out-performs the Geminids

Published December 1, 2008, 11:43 am, PhysOrg

The annual Geminid meteor shower, which will reach its maximum on the night of Dec. 13-14, usually offers the best show of the year, outperforming even the Perseid shower of August.

Discover News | Full Story


Opposition agrees to coalition with Dion as PM

Published December 1, 2008, 11:16 am, CTV Winnipeg

In a historic political move, the leaders of the Liberals, NDP and the Bloc Quebecois signed a formal agreement Monday to topple the Tories and co-operate as a coalition government for at least 18 months.

Discover News | Full Story


MicroRNA Blocker Prevented Heart Failure In Mice

Published December 1, 2008, 5:12 am, Medical News Today

An international team of scientists from universities and private industry has discovered that a tiny scrap of genetic material called microRNA-21 (miR-21) regulates gene signalling pathways that are active in heart failure and a new experimental drug was able to silence these pathways and prevent heart failure in mice.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a